Vicarious Surgical Inc. (RBOT)
USD 12.46
(-10.1%)
USD 12.46
(-10.1%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -80.66 Million USD | -0.73% |
| 2022 | -80.07 Million USD | -107.6% |
| 2021 | -38.57 Million USD | -197.07% |
| 2020 | -12.98 Million USD | -32.73% |
| 2019 | -9.78 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -17.71 Million USD | -9.96% |
| 2024 Q1 | -16.1 Million USD | -3.65% |
| 2023 FY | -80.66 Million USD | -0.73% |
| 2023 Q4 | -15.54 Million USD | 27.22% |
| 2023 Q3 | -21.35 Million USD | 0.49% |
| 2023 Q1 | -22.31 Million USD | -8.27% |
| 2023 Q2 | -21.45 Million USD | 3.84% |
| 2022 Q3 | -22.16 Million USD | -15.87% |
| 2022 Q4 | -20.61 Million USD | 7.0% |
| 2022 FY | -80.07 Million USD | -107.6% |
| 2022 Q2 | -19.12 Million USD | -5.2% |
| 2022 Q1 | -18.18 Million USD | -0.05% |
| 2021 Q1 | -5.23 Million USD | -38.24% |
| 2021 FY | -38.57 Million USD | -197.07% |
| 2021 Q4 | -18.17 Million USD | -112.25% |
| 2021 Q3 | -8.56 Million USD | -29.48% |
| 2021 Q2 | -6.61 Million USD | -26.4% |
| 2020 Q4 | -3.78 Million USD | -13.26% |
| 2020 Q1 | -2.79 Million USD | 0.0% |
| 2020 Q3 | -3.34 Million USD | -8.9% |
| 2020 FY | -12.98 Million USD | -32.73% |
| 2020 Q2 | -3.06 Million USD | -9.89% |
| 2019 FY | -9.78 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Abbott Laboratories | 6.47 Billion USD | 101.245% |
| Allurion Technologies Inc. | -78.07 Million USD | -3.315% |
| Artivion, Inc. | 5.74 Million USD | 1504.842% |
| Avanos Medical, Inc. | 4.2 Million USD | 2020.619% |
| Butterfly Network, Inc. | -145.61 Million USD | 44.601% |
| Butterfly Network, Inc. | -145.61 Million USD | 44.601% |
| Bio-Rad Laboratories, Inc. | 383.79 Million USD | 121.018% |
| Boston Scientific Corporation | 2.34 Billion USD | 103.443% |
| Perspective Therapeutics, Inc. | -15.18 Million USD | -431.327% |
| CONMED Corporation | 130.78 Million USD | 161.678% |
| Edwards Lifesciences Corporation | 1.53 Billion USD | 105.258% |
| Paragon 28, Inc. | -37.3 Million USD | -116.211% |
| Glaukos Corporation | -128.7 Million USD | 37.322% |
| Globus Medical, Inc. | 133.14 Million USD | 160.586% |
| Inspire Medical Systems, Inc. | -40.27 Million USD | -100.308% |
| Integer Holdings Corporation | 167.33 Million USD | 148.208% |
| Medtronic plc | 5.14 Billion USD | 101.568% |
| Nevro Corp. | -99.3 Million USD | 18.772% |
| Owlet, Inc. | -28.63 Million USD | -181.734% |
| Penumbra, Inc. | 73.55 Million USD | 209.674% |
| Smith & Nephew plc | 425 Million USD | 118.98% |
| Sonendo, Inc. | -57.74 Million USD | -39.698% |
| STERIS plc | 836.11 Million USD | 109.648% |
| Stryker Corporation | 3.88 Billion USD | 102.075% |
| Vapotherm, Inc. | -39.08 Million USD | -106.412% |
| Zimmer Biomet Holdings, Inc. | 1.27 Billion USD | 106.313% |